ClinicaliQ Trial Snapshot
- Comprehensive Nano – Post Market Clinical Follow-Up Study — Active Not Recruiting • Rheumatology • NCT03423953.
- Single-arm study tracking long-term safety and effectiveness outcomes of Comprehensive Nano devices to meet regulatory requirements.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
This data collection project is intended to provide clinical outcomes data to engineering, marketing as well as fulfill the post market surveillance requirements of various regulatory authorities. The study will be a prospective and one-arm. Conditions: Osteoarthritis, Avascular Necrosis, Rheumatoid Arthritis, Revision, Correction of Functional Deformity Interventions: Comprehensive Nano Lead Sponsor: Zimmer Biomet Planned Enrollment: 194 participants